Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Chem Biol Drug Des. 2021 Mar 16;97(6):1137–1150. doi: 10.1111/cbdd.13836

Scheme 4.

Scheme 4.

Synthetic pathway for compounds 18, 20 and 21a,b.

Reagents and conditions:

EDC.HCl, HOBt, INH, DIPEA, DMF, 50 °C, 18 h, 64%; (b) CDl, NH2NH2H2O, DMF, rt, 16 h, 74%; (c) EDC.HCl, HOBt, POA, DIPEA, DMF, 50 °C, 18 h, 32%; (d) EDC.HCl, DMAP, POA, THF, DCM, rt, 72 h, 70%; (e) EDC.HCl, DMAP, INH, THF, DCM, rt, 72 h, 66%; (f) EDC.HCl, HOBt, benzohydrazide, DIPEA, DMF, 50 °C, 18 h, 41%.